Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Feasibility of Using the PulsePoint to Facilitate Overdose Education and Naloxone Distribution
Sponsor: Indiana University
Summary
This study is a feasibility trial to assess whether, in a random sample of 180 agencies where PulsePoint is already active, revised procedures (hereinafter PulsePoint-OD) to facilitate opioid overdose and naloxone distribution (OEND) can successfully recruit first responder agencies and layperson responders. For this study, agency refers to a single implementation site where PulsePoint is active and that is bound by the service area or jurisdiction of the first responder agency collaborating with PulsePoint. The study will test the following hypotheses: H1: more first responder agencies will be successfully recruited by arm 2 than by arm 1. H2: more layperson responders will report engaging with OEND programming in arm 2 than in arms 1 or 3 and in arm 1 than in arm 3 \[only this hypothesis is covered by the IRB, hypothesis 1 is not human subjects research\].
Official title: The Feasibility of Using the National PulsePoint Cardiopulmonary Resuscitation Responder Network to Facilitate Overdose Education and Naloxone Distribution
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
5000
Start Date
2024-08-07
Completion Date
2026-09-30
Last Updated
2025-06-27
Healthy Volunteers
No
Conditions
Interventions
Push messages (standard)
Push messages will be developed based on best practice recruitment principles in cooperation with an external marketing team and then reviewed and finalized by the study team. Messages will be different each month and sent across 12 months. The monthly time frame was selected based on our need to balance contact with responders and research or expert opinions on push messaging saturation.
Push messages (customized)
These messages are similar to content in the standard push messages but are customized to address common misperceptions about opioid overdose and naloxone.
Locations (1)
Indiana University Bloomington
Bloomington, Indiana, United States